BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Europabio
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210318T110000
DTEND;TZID=Europe/Brussels:20210318T154500
DTSTAMP:20260629T231438
CREATED:20210128T095510Z
LAST-MODIFIED:20210212T162859Z
UID:903-1616065200-1616082300@www.europabio.org
SUMMARY:#EUIndustryWeek2021: BIO NRW
DESCRIPTION:Driving Change – How Green Chemistry and Digitalisation lead the way to a Sustainable EconomyThe focus of their event is green chemistry and sustainable processes\, focusing on how biotechnology and digitalization can contribute to the green transition. Watch the intervention from EuropaBio on on the EU perspective and what the industry suggests to drive innovation forward on the first day.
URL:https://www.europabio.org/event/bio-nrw-eu-industry-week/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-BIO-NRW.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210317T140000
DTEND;TZID=Europe/Brussels:20210317T160000
DTSTAMP:20260629T231438
CREATED:20210209T171912Z
LAST-MODIFIED:20210308T094239Z
UID:1296-1615989600-1615996800@www.europabio.org
SUMMARY:Empowering the Circular Bioeconomy through the EU Green Deal
DESCRIPTION:The 2020 Circular Economy Action Plan is one of the main blocks of the European Green Deal – Europe’s new agenda for sustainable growth – including initiatives along the entire life cycle of products and aiming at rendering sustainable products the norm in the EU. It focuses on boosting circular economy processes\, fostering sustainable consumption\, and safeguarding that the resources used are kept in the economy for as long as possible. In addition\, it remains committed to making circularity work for people\, regions\, and cities\, while leading global efforts on circular economy. \n\n\n\nAt the same time\, and closely linked with the above\, the bioeconomy offers great potential in contributing to tackle environmental and societal challenges\, such as resource efficiency\, climate change\, maintaining European competitiveness and job creation. The bioeconomy can therefore play a significant role in the EU Green Deal and particularly in the transition to a circular economy\, as outlined in a position paper developed by the European Bioeconomy Alliance. As a result\, this webinar aspires to address the above developments by providing an opportunity for discussion of how to best empower the circular bioeconomy through an enabling policy framework. \n\n\n\n\n\n\n\nEvent hosted by MEP Franc Bogovič\, Chair of the Bioeconomy Working Group of the European Parliament Intergroup on ‘Climate Change\, Biodiversity and Sustainable Development’. \n\n\n\n\n\n\n\nVIRTUAL EVENT
URL:https://www.europabio.org/event/empowering-the-circular-bioeconomy-through-the-eu-green-deal/
LOCATION:VIRTUAL\, Rue de la Science 10\, Brussels\, 1000\, Belgium
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-EUBA-Intergroup.png
ORGANIZER;CN="European Bioeconomy Alliance & EP Intergroup on CCBSD":MAILTO:ebcd.info@ebcd.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210310T140000
DTEND;TZID=Europe/Brussels:20210310T140000
DTSTAMP:20260629T231438
CREATED:20210308T092407Z
LAST-MODIFIED:20210308T093731Z
UID:1541-1615384800-1615384800@www.europabio.org
SUMMARY:All About RC(I) – Discussing the Renewable Carbon Strategy and Initiative
DESCRIPTION:Discuss the concept of renewable carbon and get answers to all your questions. Get to know the people and companies behind the Renewable Carbon Initiative and learn why your company should join. RCI members Cosun and UPM and nova-Institute will discuss and answer your questions. \n\n\n\nAbout the organizers \n\n\n\nThe Renewable Carbon Initiative (RCI) was initiated by nova-Institute after observing the struggles of the chemical and plastics industry facing the enormous challenges in meeting the climate goals set by the European Union and the sustainability expectations held by societies around the globe. It was clear that the industry has to go beyond using renewable energy. As decarbonisation is not an option for organic chemistry\, which is entirely based on the use of carbon\, an alternative strategy was needed. \n\n\n\n\n\n\n\n\n\nVIRTUAL EVENT
URL:https://www.europabio.org/event/all-about-rci-discussing-the-renewable-carbon-strategy-and-initiative/
LOCATION:Virtual Event
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/03/Event-Banners-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210309T090000
DTEND;TZID=Europe/Brussels:20210312T170000
DTSTAMP:20260629T231438
CREATED:20210209T164320Z
LAST-MODIFIED:20210308T094328Z
UID:1289-1615280400-1615568400@www.europabio.org
SUMMARY:Immunology Virtual Partnering (Member Discount)
DESCRIPTION:Over 4% of the world’s population suffers from one or more of the over 80 autoimmune diseases identified to date. A large variety of treatment approaches have already been developed to curb the detrimental effects of autoimmune diseases\, and the market continues to flourish. In fact\, by 2025 this market is estimated to exceed a global value of $150 billion. \n\n\n\nAt Inova\, our aim is to facilitate the bridge between science and business. Inova and Biotechnology Innovation Organization (BIO)\, in partnership with Evaluate\, are organizing this Immunology Virtual Partnering Event. Through online one-to-one meetings taking place 9-12 March\, researchers\, biotechs and biopharmaceutical companies will discuss the latest research from immunology congresses\, pitch ideas and partner to prioritize the most promising research efforts. \n\n\n\nThis event will leverage Inova and Biotechnology Innovation Organization (BIO)’s biopharma industry expertise\, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide. \n\n\n\n\n\n\n\nEuropaBio Members can benefit from a 15% discount. Please liaise with Martina Cilia for further details. \n\n\n\n\n\n\n\nVIRTUAL EVENT
URL:https://www.europabio.org/event/immunology-virtual-partnering-member-discount/
LOCATION:VIRTUAL\, 89 Rue Tronchet\, Lyon\, 69006\, France
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-Immunology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210304T140000
DTEND;TZID=Europe/Brussels:20210304T153000
DTSTAMP:20260629T231438
CREATED:20210211T123919Z
LAST-MODIFIED:20210225T120052Z
UID:1355-1614866400-1614871800@www.europabio.org
SUMMARY:Measuring the Economic Footprint of the Biotechnology Industry in Europe
DESCRIPTION:Landscape and Positions for Economic Development: Industry and policy discussions to deliver biotechnology in Europe. \n\n\n\n\n\nEuropean GDP benefitted by €38.5 bn in 2018\, in the recent study from EuropaBio ‘Measuring the Economic Footprint of the Biotechnology Industry in Europe’.  The study looked at the economic impact of the biotechnology industry within the (then) 28 European member states\, in terms of gross value added (GVA)\, employment and trade.  Including spill over effects\, that number rises to €78.7bn.  The direct contribution adds up to about 1.5% of total industrial GVA within the countries assessed\, supported by 223\,000 direct jobs rising to over 700\,000 with associated employment. \n\n\n\nVery few other sectors enhance quality of life\, knowledge\, innovation\, productivity\, andenvironmental protection as biotechnology does.  \n\n\n\nJoin EuropaBio on March 4 to find out more about the the economic footprint of biotechnology in Europe and be part of the discussion on its role in future economic recovery and delivering healthy people and planet.
URL:https://www.europabio.org/event/measuring-the-economic-footprint-of-the-biotechnology-industry-in-europe-landscape-and-positions-for-development/
CATEGORIES:EuropaBio,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2021/02/WebEx-Event-Banner-WifOR.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210303T084500
DTEND;TZID=Europe/Brussels:20210303T121500
DTSTAMP:20260629T231438
CREATED:20210203T212715Z
LAST-MODIFIED:20210212T163056Z
UID:1157-1614761100-1614773700@www.europabio.org
SUMMARY:Annual Conference on EU Law in the Pharmaceutical Sector
DESCRIPTION:Annual Conference on EU Law in the Pharmaceutical Sector (3-5 March 2021) \n\n\n\nObjective \n\n\n\nThis online conference will bring legal practitioners working with the pharmaceutical sector up-to-date on the latest relevant regulatory developments\, legislative initiatives and case law. \n\n\n\nKey topics \n\n\n\nImpact of recent rulings from the CJEU on supplementary protection certificates\, patent settlements\, and online sales of medicinal products Ongoing European Commission cases on competition lawTowards a European Health Data SpaceThe European Commission’s Pharmaceutical StrategyInitiatives related to Covid-19: shortage of medicines\, dependency on raw materials from outside the EU\, cooperation between Member StatesFair competition between pharmaceutical companies in times of Covid-19 and Brexit\n\n\n\nWho should attend? \n\n\n\nIn-house counsel\, lawyers in private practice\, lawyers in national ministries and authorities dealing with regulation of the sector. \n\n\n\nInteractive online event \n\n\n\nThe conference will be hosted on ERA’s own online platform. You will be able to interact immediately and directly with our top-level speakers and other participants. We will make the most of the technical tools available to deliver an intensive\, interactive experience. As the platform is hosted on our own server\, the highest security settings will be applied to ensure that you can participate safely in this high-quality online conference. \n\n\n\n\n\n\n\nNetworking \n\n\n\nNetworking opportunities where participants can meet each other and chat with speakers will be offered. \n\n\n\nEuropaBio Members can benefit of a 25% discount on the price. Please liaise with Martina Cilia (m.cilia@europabio.org) to receive detailed information on the discount code.
URL:https://www.europabio.org/event/annual-conference-on-eu-law-in-the-pharmaceutical-sector/
LOCATION:VIRTUAL\, Metzer Allee 4\, Trier\, D-54295\, Germany
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-ERA.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210302T090000
DTEND;TZID=Europe/Brussels:20210305T170000
DTSTAMP:20260629T231438
CREATED:20210209T163156Z
LAST-MODIFIED:20210212T163115Z
UID:1278-1614675600-1614963600@www.europabio.org
SUMMARY:Oncology Virtual Partnering (Member Discount)
DESCRIPTION:Oncology is one of the most challenging areas for research and development\, but there are critical junctures where the right environment is crucial for success – and where partnering can help bring the best science forward. \n\n\n\nAt Inova\, our aim is to facilitate the bridge between science and business. Inova and Biotechnology Innovation Organization (BIO)\, in partnership with Evaluate\, are organizing this Oncology Virtual Partnering Event. Through online one-to-one meetings taking place 2 – 5 March\, researchers\, biotechs and biopharmaceutical companies will discuss the latest research from oncology congresses\, pitch ideas and partner to prioritize the most promising research efforts. \n\n\n\nThis event will leverage Inova and Biotechnology Innovation Organization (BIO)’s biopharma industry expertise\, leading digital networking platform and years of experience organizing partnering events to connect scientific and business communities for the benefit of patients worldwide. \n\n\n\n\n\n\n\nEuropaBio Members can benefit from 15% discount. Please liaise with Martina Cilia for further details.
URL:https://www.europabio.org/event/oncology-virtual-partnering-member-discount/
LOCATION:VIRTUAL\, Inova Software\, 89 Rue Tronchet\, Lyon\, 69006\, France
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-Oncology.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210301T093000
DTEND;TZID=Europe/Brussels:20210302T170000
DTSTAMP:20260629T231438
CREATED:20210203T211251Z
LAST-MODIFIED:20210212T163133Z
UID:1150-1614591000-1614704400@www.europabio.org
SUMMARY:1st International Conference on Rare Diseases
DESCRIPTION:1st International Conference on Rare Diseases \n\n\n\nDifferent infrastructures and organisational arrangements are required in each country to address the healthcare needs of its rare disease population in an effective way. Whether a single rare disease affects thousands or only a handful of individuals\, they all share similar challenges to get a timely diagnosis\, face the same barriers to access highly specialized care and treatment options and need to deal with a substantial psychosocial burden. \n\n\n\nThe health of people living with a rare disease should not be left to luck or chance especially amidst the COVID-19 pandemic. Planning ahead requires all stakeholders to acknowledge their individual responsibility to build a successful pathway from diagnosis to access and at the same time\, commit to work together in a much more agile and coordinated way than what we have seen so far. If we fail to do so\, we will have failed the 30 million people living with a rare disease in Europe. \n\n\n\nThe 1st International Conference on Rare Diseases “Building a Pathway from Diagnosis to Access” recognises that the next decade holds great potential for improvement and that while we cannot predict the future\, we all have a role in preparing for it. As the EU shapes its future regulations\, strategies and access policies\, this conference will serve as an opportunity to press the ‘pause button’ and take the time to co-create policy options today that can lead to a better patient journey in the future. \n\n\n\nEngaging all stakeholders to take action\, the 1st International Conference on Rare Diseases aspires to bring together all stakeholders in the rare disease community – patient representatives\, policy makers\, clinicians\, researchers\, industry representatives\, payers and regulators to exchange invaluable knowledge with the aim to enhance dialogue and promote policy changes to help build a better pathway from Diagnosis to Access for Rare Diseases.
URL:https://www.europabio.org/event/1st-international-conference-on-rare-diseases/
LOCATION:VIRTUAL\, 338. Kleisthenous Str.\, Gerakas\, Attiki\, 15344\, Greece
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-Rare-Diseases.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210223T110000
DTEND;TZID=Europe/Brussels:20210223T123000
DTSTAMP:20260629T231438
CREATED:20210203T204218Z
LAST-MODIFIED:20210225T111812Z
UID:1135-1614078000-1614083400@www.europabio.org
SUMMARY:#EUIndustryWeek2021: The next Industrial Revolution is a Bio Revolution
DESCRIPTION:Global challenges like COVID-19 and climate change require a range of solutions\, including those coming from innovative biotechnology. Life sciences and biotechnology is a key industrial sector which can play a transformative role in securing the EU’s competitive edge in health and sustainability.From new treatments for rare diseases to bio-based products\, biotechnology can revolutionize our approach to global challenges\, paving the way for an industrial revolution driven by the life sciences. \n\n\n\nJoin EuropaBio for presentations and discussion around the key issues where biotechnology is making a difference and how the scientific and business landscape will enable it in the future.Our panel will discuss the innovation potential of industrial and healthcare biotechnology for long term and future EU competitiveness\, including biotech SMEs as a critical part of the EU life sciences ecosystem\, and the need for a strategic approach for investment and innovation.Confirmed speakers: \n\n\n\nDr Marcus Remmers\, CTO\, Royal DSMMr Geoffrey Pot\, VP operations\, Takeda & bio.be ChairmanProf Isabel Rocha\, Pro-Rector of Nova University of LisbonDr Armin Spök\, TU Graz\, CHIC H2020 Project\n\n\n\nThis webinar is hosted by EuropaBio under the umbrella of the EU Industry Days and will be moderated by Dr Claire Skentelbery (Director-General\, EuropaBio).You can download below the speakers’ presentations: \n\n\n\nEU-Industry-Days-EuropaBio-Event-Armin-Spoek-PresentationDownload\n\n\n\nEU-Industry-Days-EuropaBio-Event-Geoffrey-Pot-PresentationDownload\n\n\n\nEU-Industry-Days-EuropaBio-Event-Isabel-Rocha-PresentationDownload\n\n\n\nEU-Industry-Days-EuropaBio-Event-Marcus-Remmers-PresentationDownload
URL:https://www.europabio.org/event/euindustryweek2021-the-next-industrial-revolution-is-a-bio-revolution/
LOCATION:VIRTUAL\, Avenue des Arts 53\, Brussels\, 1000\, Belgium
CATEGORIES:EuropaBio,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-EU-Ind.-Week-Ebio.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210218T113000
DTEND;TZID=Europe/Brussels:20210218T130000
DTSTAMP:20260629T231438
CREATED:20210127T062632Z
LAST-MODIFIED:20210212T163254Z
UID:720-1613647800-1613653200@www.europabio.org
SUMMARY:EuropaBio National Associations Council: Brexit Impact for UK and Europe (Member-only webinar)
DESCRIPTION:As part of the EuropaBio National Associations Council\, this meeting kick starts a long term Brexit monitoring Group within EuropaBio which will support members to understand and manage Brexit changes and for the National Associations Council to identify priority topics for joint communications.
URL:https://www.europabio.org/event/brexit-impact-monitoring-members-only/
CATEGORIES:EuropaBio,Healthcare Biotech,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/02/Event-Banner-Brexit-NAC.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210217T160000
DTEND;TZID=Europe/Brussels:20210217T170000
DTSTAMP:20260629T231438
CREATED:20210128T145149Z
LAST-MODIFIED:20210212T163952Z
UID:952-1613577600-1613581200@www.europabio.org
SUMMARY:KeyGene’s two-part webinar on PanGenomes: needs\, value and applications (part 1)
DESCRIPTION:This two-part webinar on PanGenomes\, which Keygene organizes together with an academic partner and Allen Sessions from BASF\, will explain what one needs to construct PanGenomes and highlight their value in breeding and research. PanGenomes describe the available genetic diversity within\, for instance\, plant species\, crops or germplasm collections. Because of diminishing costs of genome sequencing\, increasing speed of reference genomes construction and advances in bioinformatics\, PanGenomes have become an accessible tool. The genome insights delivered by PanGenomes can spectacularly speed up and contribute to plant breeding and research.
URL:https://www.europabio.org/event/keygenes-two-part-webinar-on-pangenomes-needs-value-and-applications/
CATEGORIES:External
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-KeyGene1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210217T130000
DTEND;TZID=Europe/Brussels:20210217T170000
DTSTAMP:20260629T231438
CREATED:20210203T205656Z
LAST-MODIFIED:20210212T164046Z
UID:1145-1613566800-1613581200@www.europabio.org
SUMMARY:#EUIndustryWeek2021: Bio4Products & Rehap
DESCRIPTION:Moving Towards a Competitive European Bioeconomy: Emerging Biorefinery Technologies & Pathways to Deployment \n\n\n\nFor Europe to move towards a competitive bioeconomy\, is it is essential that biorefinery technologies developed in the lab and at pilot scale are upscaled and deployed at an industrial scale. Industry and policy makers must work together to create commercial pathways to this greener future – but how? \n\n\n\nThis interactive event brings together researchers\, industry leaders and policy makers to discuss how the European bioeconomy can take green technology from idea to deployment and who needs to do what to make this happen. \n\n\n\nShort agenda: \n\n\n\n\n\n13:00 Introductions and keynote from the EU \n\n\n\n13:30 Technical sessions – project achievements Feedstock\, processes and new products Interactive session with audience Q&A \n\n\n\n15:00 Coffee break \n\n\n\n15:30 First panel session From idea to deployment – an industry view \n\n\n\n16:15 Second panel session Rollout of biorefinery technology – policy perspective \n\n\n\n\n\nThe event is organised by two EU-funded SPIRE projects\, Bio4Products and Rehap\, both successful in identifying biomass availability and developing innovative new conversion processes and bio-based products. The projects have received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements number 723070 and 723670 respectively.
URL:https://www.europabio.org/event/euindustryweek2021-bio4products-rehap/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-EU-Ind.-Week.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210217T090000
DTEND;TZID=Europe/Brussels:20210217T180000
DTSTAMP:20260629T231438
CREATED:20210122T073836Z
LAST-MODIFIED:20210212T164114Z
UID:547-1613552400-1613584800@www.europabio.org
SUMMARY:nova Session: Renewable Polymers: Production and Trends 2020-2025 (Member Discount)
DESCRIPTION:The only way for chemicals and plastics to become sustainable\, climate-friendly and part of the circular economy is the complete substitution of fossil carbon with renewable carbon from alternative sources: biomass\, CO2 and recycling. Sold out PLA in 2019 has led to the installation of increased capacities in 2020\, PE and PP made from bio-based naphtha are breaking ground and future expansion for bio-based polyamides will come into place\, growth for bio-based polymers is expected to over 6 % until 2025. Additionally\, the use of CO2 as chemical feedstock for polymers has been intensively diversified. Besides the long-established use of CO2 for the synthesis of polycarbonates\, also polyurethanes can already be based on it. Optimised technology approaches in fermentation\, electrochemistry and catalysts for conversion are emerging and broaden the CO2-based polymer portfolio. \n\n\n\nGet the newest market developments for bio-based building blocks and polymers as well as the latest technology developments for CO2-based polymers. Join the nova Session and discuss with the experts. The nova-Institute invites to the nova Session “Renewable Polymers: Production and Trends 2020-2025” on 17 February\, 2021. The all-day workshop will be an online event. The workshop will focus on the market report “Bio-based Building Blocks and Polymers –Global Capacities\, Production and Trends 2020-2025” and the trend report “Carbon dioxide (CO2) as chemical feedstock for polymers – technologies\, polymers\, developers and producers” published in January. \n\n\n\nThe main authors of the report will participate in the workshop and discuss with you. The nova Session offers the unique opportunity to exchange information about current market and technology developments at the highest level. \n\n\n\nParticipants are welcome to submit their specific topics of interest beforehand or put them up for discussion at the session. \n\n\n\nEuropaBio members receive a 20% discount on the registration fee. Please contact Martina Cilia for more information. \n\n\n\n\nVISIT THE WEBSITE
URL:https://www.europabio.org/event/nova-session-renewable-polymers-production-and-trends-2020-2025-member-discount/
LOCATION:VIRTUAL & ON SITE (Cologne)\, nova-Institut GmbH - Chemiepark Knapsack Industriestraße 300 50354 Germany\, Huerth\, Azerbaijan
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/Event-Banner-nova.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210201T090000
DTEND;TZID=Europe/Brussels:20210219T180000
DTSTAMP:20260629T231438
CREATED:20210122T073259Z
LAST-MODIFIED:20210212T164153Z
UID:543-1612170000-1613757600@www.europabio.org
SUMMARY:BIOKET 2021
DESCRIPTION:Register now\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \nSecond International Conference on Cellulose Fibres\, the fastest growing fibre group in textiles\, the largest investment sector in the bio-based economy and the solution for avoiding microplastics\nWith 210 participants and 15 exhibitors from 26 different countries\, the “1st International Conference on Cellulose Fibres” in 2020 was a great success and exceeded all expectations. The trade press wrote: “nova-Institute hits the mark with new conference”. The focus of the conference was on markets\, technologies and sustainability – and especially alternative cellulose feedstocks. \nBuilding on this success\, the 2nd International Conference on Cellulose Fibres will again cover the entire value chain from the lignocellulosic feedstock\, dissolving pulp\, cellulose fibres – such as rayon\, viscose\, modal or lyocell and new developments\, to a wide range of applications\, woven textiles (clothing) and non-wovens (wipes and technical applications). All these sectors have significantly gained in dynamics over the last few years. \nCellulose fibres are a success story within the textiles market with a cumulated annual growth rate (CAGR) between 5 and 10% over the last ten years – similar growth rates are expected in the next decade. This makes cellulose fibres the fastest growing fibre group in the textile industry and also the largest investment sector in the bio-based economy worldwide. The challenge now is to achieve a balance between the ongoing capacity expansion and the growing demand – to avoid over capacities\, but also to cover the growing demand of the big brands.\nThe high growth rates are driven by the demand for natural fibres (and bottlenecks in cotton)\, the microplastic problem and possible bans for plastic fibres. All three drivers will continue to play a significant role in the future development of the sector. \n\n\n\n\n\n\n\nVISIT WEBSITE
URL:https://www.europabio.org/event/bioket-2021/
LOCATION:VIRTUAL & ON SITE (Cologne)\, nova-Institut GmbH - Chemiepark Knapsack Industriestraße 300 50354 Germany\, Huerth\, Azerbaijan
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2021/01/bioket.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20210130T000000
DTEND;TZID=Europe/Brussels:20210204T235959
DTSTAMP:20260629T231438
CREATED:20210114T090035Z
LAST-MODIFIED:20210209T153647Z
UID:126-1611964800-1612483199@www.europabio.org
SUMMARY:2nd International Conference on Cellulose Fibres (Member Discount)
DESCRIPTION:Register now\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \nSecond International Conference on Cellulose Fibres\, the fastest growing fibre group in textiles\, the largest investment sector in the bio-based economy and the solution for avoiding microplastics\nWith 210 participants and 15 exhibitors from 26 different countries\, the “1st International Conference on Cellulose Fibres” in 2020 was a great success and exceeded all expectations. The trade press wrote: “nova-Institute hits the mark with new conference”. The focus of the conference was on markets\, technologies and sustainability – and especially alternative cellulose feedstocks. \nBuilding on this success\, the 2nd International Conference on Cellulose Fibres will again cover the entire value chain from the lignocellulosic feedstock\, dissolving pulp\, cellulose fibres – such as rayon\, viscose\, modal or lyocell and new developments\, to a wide range of applications\, woven textiles (clothing) and non-wovens (wipes and technical applications). All these sectors have significantly gained in dynamics over the last few years. \nCellulose fibres are a success story within the textiles market with a cumulated annual growth rate (CAGR) between 5 and 10% over the last ten years – similar growth rates are expected in the next decade. This makes cellulose fibres the fastest growing fibre group in the textile industry and also the largest investment sector in the bio-based economy worldwide. The challenge now is to achieve a balance between the ongoing capacity expansion and the growing demand – to avoid over capacities\, but also to cover the growing demand of the big brands.\nThe high growth rates are driven by the demand for natural fibres (and bottlenecks in cotton)\, the microplastic problem and possible bans for plastic fibres. All three drivers will continue to play a significant role in the future development of the sector. \n\n\n\n\n\n\n\nRegister now
URL:https://www.europabio.org/event/2nd-international-conference-on-cellulose-fibres-member-discount/
LOCATION:VIRTUAL & ON SITE (Cologne)\, nova-Institut GmbH - Chemiepark Knapsack Industriestraße 300 50354 Germany\, Huerth\, Azerbaijan
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/jpeg:https://www.europabio.org/wp-content/uploads/2020/08/finance3-sectionbg2.jpg
END:VEVENT
END:VCALENDAR